Carvedilol (Coreg) Considerations for Use* US/FDA Approved Indication: Heart Rate Control for Atrial Fibrillation

Carvedilol (Coreg) Considerations for Use* US/FDA Approved Indication: Heart Rate Control for Atrial Fibrillation

Carvedilol (Coreg) Considerations for Use* US/FDA Approved Indication: Heart Rate Control for Atrial Fibrillation Black Box Warning* Abrupt cessation may exacerbate angina pectoris and MI. Mechanism of Action Blocks binding of catecholamines to postsynaptic alpha-1, beta-1, and beta-2 receptors Dosing† Non-acute setting or maintenance - Immediate release: 3.125 to 25 mg PO every 12 hrs (up to 50 mg every 12 hrs for patients >85 kg). Non-acute setting or maintenance - Extended-release: 10 to 80 mg PO daily Hepatic Impairment: Not recommended for clinically-evident hepatic impairment Renal Impairment: No dosage adjustments are needed Contraindications Asthma AV block Bradycardia cardiogenic shock decompensated heart failure sick sinus syndrome without pacer hepatic disease Major Side Effects hypotension, bradycardia, bronchospasm, HF Dosage forms and Strengths PO: 3.125 mg, 6.25 mg, 12.5 mg, 25 mg immediate-release tablets (Coreg®) 10 mg, 20 mg, 40 mg, 80 mg extended-release capsules (Coreg® CR) Special Notes Non-selective beta-blocker. Abrupt cessation my precipitate angina, MI, arrhythmias, or rebound HTN; discontinue by tapering over 1-2 weeks. Dosing conversion: 3.125 mg immediate-release BID = 10 mg CR 6.25 mg immediate-release BID = 20 mg CR 12.5 mg mg immediate-release BID = 40 mg CR 25 mg mg immediate-release BID = 80 mg CR Counseling Do not abruptly discontinue without physician’s advice. Take with food and eight ounces of water at the same time every day Separate extended-release formulation and alcohol by at least 2 hours Take controlled-release formulation in the morning; the contents may be sprinkled over applesauce and consumed immediately *Refer to prescribing information for more complete information. †Dosages given in the table may differ from those recommended by the manufacturers. Sources: 1. American College of Cardiology (ACC), American Heart Association (AHA), and the European Society of Cardiology (ESC). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation. Washington, DC: American College of Cardiology. 2. Heart Rhythm Society. AF360 Pocket Guide: Practical Rate and Rhythm Management of Atrial Fibrillation. 2010, Washington, DC: Heart Rhythm Society. 3. Tarascon Pocket Pharmacopoeia®2012. .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    1 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us